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Our researches have shown that gestational stress causes exacerbation of inflammatory pain in the offspring; the maternal 5-HT1A
agonist buspirone before the stress prevents the adverse effect. The serotonergic system and hypothalamo-pituitary-adrenal (HPA)
axis are closely interrelated. However, interrelations between inflammatory pain and the HPA axis during the hyporeactive period
of the latter have not been studied. The present research demonstrates that formalin-induced pain causes a gradual and prolonged
increase in plasma corticosterone level in 7-day-oldmale rats; twenty-four hours after injection of formalin, the basal corticosterone
level still exceeds the initial basal corticosterone value. Chronic treatments of rat dams with buspirone before restraint stress
during gestation normalize in the offspring pain-like behavior and induce during the acute phase in the formalin test the stronger
corticosterone increase as compared to the stress hormonal elevation in animalswith other prenatal treatments.Negative correlation
between plasma corticosterone level and the number of flexes+shakes is revealed in buspirone+stress rats. The new data enhance
the idea about relativity of the HPA axis hyporeactive period and suggest that maternal buspirone prior to stress during gestation
may enhance an adaptive mechanism of the inflammatory nociceptive system in the infant male offspring through activation of the
HPA axis peripheral link.
1. Introduction
Interrelations between the serotonergic system and
hypothalamo-pituitary-adrenal (HPA) axis determine the
formation of mechanisms of stress adaptation [1–6]. Pain is a
stress and therefore can activate the HPA axis [7–15]. In this
case, inflammatory pain is still not clearly understood, and
the data available are inconsistent [9, 14–17]. In a widely used
model of inflammatory pain, the formalin test, activation
of the HPA axis with the nociceptive stimulus formalin
has been shown on adult awake rodents and differences
in the dynamics of release of ACTH and corticosterone
in response to pain impact found [8, 9, 17–19]. The HPA
axis during the postnatal development goes through the
period of hyporesponsiveness, which extends from the
second to fourteenth postnatal days and is characterized
by a low level of the response of adrenals to many stress
stimuli [20]. Investigations of formalin-induced pain effects
on the HPA axis in infant rats could elucidate unexplored
previously interrelations between the tonic nociceptive and
stress systems during the period of hyporesponsiveness of
the latter. We revealed for the first time that prenatal stress
induces strengthening inflammatory pain-related response
in the formalin test and decrease of adaptive capacities in
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infant rats; chronic injections of an agonist of serotonin
(5-HT) receptors 1A (5-HT1A) buspirone to dams prior
to stress during gestation cancel the adverse consequences
of the stress in the offspring [21]. In prenatally stressed
individuals, abnormalities in the HPA axis function [22] and
neurotransmitter systems including the serotonergic one
[23] were shown.
Serotonin acts as a growth factor in early cell division,
migration, and differentiation in the brain specifically in
development of the serotonergic system [24–27]. Many of
regulator influences on developing neurons 5-HT mediates
through presynaptic 5-HT1A autoreceptors in the raphe
nuclei [28, 29]. Later 5-HT and 5-HT1A receptors take part
in many kinds of behavior. The serotonergic system plays
an important role in pain transmission, its processing and
regulation [30–33]. Buspirone, serotoninergic anxiolytic and
antidepressant, mediates its effect through the serotonergic
system and the HPA axis. There are synergistic interrela-
tions between these systems impaired in prenatally stressed
individuals [23, 34–36]. A peculiar mechanism of buspirone
action has not been completely understood; it is also true for
its analgesic effect. Studies of effects of buspirone, an agonist
of presynaptic and a partial agonist of 5-HT1A receptors, on
the nociceptive system are limited, and the results obtained
do not coincide [37, 38]. Prenatal effect of buspirone on the
nociceptive system has not been studied until our researches.
Activation of the antinociceptive descending serotonergic
system and the decrease in hyperactivity of the HPA axis are
considered as potential mechanisms of analgesic action of
antidepressants. Activating effects of buspirone on the HPA
system are found in adult persons [39]. It may be suggested
that the period of hyporesponsiveness of the HPA, which is
characterized by a low level of reaction of adrenals in response
to many stress stimuli [20], will allow to prevent activating
influences of buspirone on the HPA axis.
The aim of our work was to study effects of maternal
buspirone prior to stress during gestation on the dynamics of
the inflammatory pain-like behavior and stress response of
corticosterone during the formalin test in the infant male rat
offspring and also to evaluate correlation between pain-like
and hormonal parameters.
2. Materials and Methods
2.1. Animals. All experimental procedures were approved by
the Local Ethics Committee for Animal Experiments of the
I. P. Pavlov Institute of Physiology and followed the guide-
lines published by the Committee for Research and Ethical
Issues of the IASP on ethical standards for investigations of
experimental pain in animals.
Adult female rats and male rats (Wistar) at the age
of 90 days were obtained from the vivarium of the I. P.
Pavlov Institute of Physiology RAN, St. Petersburg, Russia.
Two days after adaptation, the rats were mated. The days
of insemination and delivery were considered as gestational
day (GD) 0 and postnatal day (PD) 0, respectively. All
animals were maintained at constant temperature (20–22∘C)
under the standard light-dark cycle (8.00AM–8.00 PM) with
unrestricted access to food and water. Seventeen rat dams
(controls) were not exposed to any impacts during gestation.
The equal number of remaining dams (𝑛 = 68) was ran-
domly treated with the 5-HT1A agonist buspirone (buspirone
hydrochloride, Sigma, 3mg/kg, 1mL, i.p. at 9 AM) or with
injection of saline (control animals from the same litters, in
the same conditions of injections) from GD9 to GD21. A half
of the treated rats from each groupwere randomly exposed to
restraint stress for 60min (in 5min after buspirone injection)
from GD15 to GD21. All influences on gestational females
were identical to those used in our previous study [21]. The
dose of buspirone was sufficient for inducing an anxiolytic
effect in adult rats [40] and did not exceed the dose used for
pregnant rat dams to protect the fetal serotonergic system
against damaging effects of in utero ethanol exposure [41].
It should be noted that such dose of buspirone was not able
to implicate dopamine and norepinephrine in the mediation
of buspirone effects [42, 43]. Litters were called to 8 pups
(4 females and 4 males, as far as possible) in 48 hours after
birth. In the study, 7-day-old males born to the dams with the
above-mentioned treatments during gestation and to control
dams were used; females and remaining males were used in
other researches. There were 245 males offspring of control,
saline, saline + stress, buspirone, and buspirone + stress dams
in the study with formalin injection (about 6–8 males per a
group, no more than 3 animals from one dam); in addition,
80 male rats from the same litters were used as control for the
formalin, with saline injection into the hind limb.
2.2. Experimental Formalin-Induced Inflammatory Pain in
Infant Male Rats. Formalin test is widely used for evaluation
of tonic inflammatory pain and analgesic effects of various
pharmacological drugs [9, 44–47]. Flexing and shaking
behaviors are the specific expression of inflammatory pain-
related behavior in the formalin test in both infant and
adult rats [44, 45, 48, 49]; we used the formalin test as
previously described [21].The formalin test allows evaluating
acute nociception (the first phase, 5–10min after formalin
injection), tonic persistent nociception (the second phase
about 30–40min), and functional activity of the descending
serotonergic inhibitory system (the interphase about 3–
10min). The second phase appears during postnatal devel-
opment when the descending serotonergic inhibitory system
matures [45, 46]. Characteristics of the phases depend on
many factors including age and sex [50].
Eachmale rat was taken from the nest, injected intraplan-
tarly to the left hindpaw with formalin solution (2.5%, 10 𝜇L),
and placed singly in awarm (25∘C) chamber (25× 20× 10 cm)
with transparent glass walls encircled by mirrors to improve
the observation of the animal’s behavior [21, 51]. The number
of flexes + shakes was recorded using a computer program
that allows recording, quantifying, and analyzing the pain-
related behavior. In each group of the males, the number of
flexes + shakes was averaged for 3, 9, 21, 30, and 60min after
formalin injection. Each animal was used only once.
2.3. Corticosterone Determination in Infant Male Rats. Blood
samples were collected by decapitation in the rats with differ-
ent prenatal treatments and in controls at 09:00-10:00 before
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and 24 hours after the formalin test for determination of basal
plasma corticosterone levels. During the formalin-induced
pain, blood sampling by decapitation occurred at 3, 9, 21, 30,
and 60min after formalin injection. The blood samples were
centrifuged and the plasma was kept at −20∘C nomore than a
week. The plasma corticosterone (SIGMA-ALDRICH, USA)
levels (𝜇g/dL) were measured by microfluorometry [52].
2.4. Statistical Analysis. Data are presented as mean ±
S.D. Formalin-evoked flexing + shaking, and corticosterone
responseswere analyzed by two-wayANOVA,with treatment
(control, saline, saline + stress, buspirone, and buspirone +
stress) and time as factors. Behavioral and corticosterone
responses during 3, 9, 21, 30, and 60 minutes were separately
evaluated. Comparisons between the basal levels and the
data over time as well as comparisons between groups
with different types of treatment were conducted using tests
of simple effects. Besides pairwise comparisons, t-test and
Mann-Whitney test were performed. Pearson and Spear-
man Correlations were calculated to estimate relationships
between behavioral and hormonal variables. For all tests, 𝑃 <
0.05 was considered to be statistically significant.
3. Results
Two-way ANOVA applied to pain-like responses (Figure 1)
resulted in a significant effect of the factor prenatal treatments
(F(4,114) = 5.094, 𝑃 = 0.001); (F(3,114) = 56.545, 𝑃 < 0.001).
Tests of simple effects showed a significant increase in the
number of flexes + shakes at 9, 30, and 60min after formalin
injection in saline + stress as compared to saline (𝑃 < 0.05,
𝑃 < 0.05, and 𝑃 = 0.014, resp.) and in saline + stress
as compared to the control (𝑃 = 0.002, 𝑃 = 0.03, resp.)
(Figure 1). Tests of simple effects showed a decrease in the
number of flexes + shakes at 9, 21, 30, and 60min after
formalin injection in buspirone + stress as compared to saline
+ stress (𝑃 = 0.002, 𝑃 < 0.05, 𝑃 < 0.05, and 𝑃 = 0.002, resp.)
(Figure 1).
Two-way ANOVA applied to the level of plasma cor-
ticosterone (Figure 2) resulted in a significant effect of the
factor prenatal treatments (F(4,170) = 2.706, P = 0.002)
and time (F(5,170) = 22.574, P < 0.001). The significant
effects of factor prenatal treatment on dependent variable
corticosterone were revealed at 3 and 9min (F(4,170) = 2.322,
P < 0.05; F(4,170) = 3.634, P < 0.007, resp.). Tests of simple
effects showed the corticosterone level at 3min after formalin
injectionwas higher than basal level (𝑃 = 0.037) in buspirone
+ stress males; during the following time periods (9, 21, 30,
and 60min), corticosterone was higher than basal level in
animals with all prenatal treatments (𝑃 < 0.05) (Figure 2).
Tests of simple effects (pairwise comparisons) or/and Mann-
Whitney test showed that only in buspirone + stress males
at 3 and 9min after formalin injection, the corticosterone
level was higher than similar hormonal level in animals
with all different prenatal treatments (𝑃 < 0.05). During
the following time course of formalin-induced pain, there
were no differences in the stress level of hormone between
animals with different prenatal treatments. Tests of simple
effects (pairwise comparisons) or/and Mann-Whitney test
showed that in the course of inflammatory pain, the level of
plasma corticosterone gradually increased (F5,170) = 22.574,
P < 0.001) and to the end of the formalin test (at 60min)
was significantly higher than basal level (P = 0.001). Pairwise
comparisons showed that basal level 24 h after the formalin
test was greater than that prior to the formalin test (P = 0.001)
in animals with all prenatal treatments (𝑃 < 0.05) (Figure 2).
There were no significant differences in indices under
study in buspirone, saline, and control animals.
Correlation between plasma corticosterone level and the
number of flexes + shakes was revealed in buspirone + stress
male rats at 3 (−𝑟 = 0.925, 𝑃 = 0.008), 9min (−𝑟 = 0.937, 𝑃 =
0.002), and 60min (−𝑟 = 0.690, 𝑃 = 0.05) and in control rats
at 3min (−𝑟 = 0.90, 𝑃 = 0.037) after injection of formalin.
Injection of saline to the left hindpaw (controls for
formalin injection) resulted in a few weak flexes + shakes
during some first minutes after injection only in prenatally
stressedmales. Corticosterone response to pain was a specific
reaction; in control animals, an increase in the plasma
corticosterone in response to the procedure of saline injection
into the paw was less prolonged (no more than 30 min)
and did not exceed the value of corticosterone response to
formalin-induced pain (the data are not shown in the table).
4. Discussion
The dynamics of corticosterone stress response to inflam-
matory pain and participation of 5-HT1A receptors in it
were investigated in the present study in 7-day-old male
rats with various prenatal treatments. Evidence of increased
formalin-induced pain in prenatally stressed animals is in
agreementwith the data thatwe obtained earlier [21]. Chronic
treatments of rat dams with the 5-HT1A agonist buspirone
prior to stress during gestational period increased resistance
of the tonic nociceptive system normalizing behavior in the
inflammatory pain model and changed the time course of
stress corticosterone response to formalin-induced pain in
the offspring.
Before our studies, in a widely accepted model of inflam-
matory pain, the formalin test, it was demonstrated in adult
awake rats that the nociceptive stimulus formalin induced
activation of the HPA axis and increased concentration of
ACTHand corticosterone [9, 13, 19]. Interestingly, the authors
that found the peak of the corticosterone release at 30min
and its restored level at 80min after formalin injection
concluded that the resulting release of corticosterone is
not antinociceptive as neither adrenalectomy nor high-dose
dexamethasone changed behavioral nociceptive responses
[9]. It is worthy to note that peaked time in release of
corticosterone in response to the formalin test as well as
the time of the hormonal restoration level after formalin
injection vary according to the authors from the 15–60min
to 60–120min, respectively [9, 13, 19]. These differences
may be attributed to peculiarities of the formalin test. The
behavioral response in the formalin test, represented by acute
and tonic phases of different chemical nature, depends on
concentrations and volumes of formalin solution, a place
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Figure 1: Pain-like responses recorded over different periods of time
(3, 9, 21, 30, and 60min) after injection of formalin (mean ± SEM)
in 7-day-old male rats with different prenatal treatments. ∗P < 0.05
different from saline; +P < 0.05 different from saline + stress; #P <
0.05 different from controls.
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Figure 2: Basal levels of corticosterone and plasma corticosterone
levels (𝜇g/dl) determined 3, 9, 21, 30, and 60min after injection
of formalin (mean ± SEM) in 7-day-old male rats with different
prenatal treatments. ∗P < 0.05 different from the basal level; +P <
0.05 different from the control, saline, saline + stress, and buspirone;
#P < 0.05 different from the basal level before injection of formalin.
of its injection, temperature in the room, a strain of rats,
and conditions of experimental performances [9, 50, 53,
54]. These factors determine involvement in the response of
various mediators influencing the intensity and dynamics of
release of corticosterone.
Our study is the first to evaluate the dynamics of corticos-
terone release in conditions of inflammatory pain in infant
rats during the hyporesponsive period of the HPA axis [20].
The new data obtained testify that inflammatory formalin-
induced pain evokes the stress response of corticosterone in
male rats during the hyporesponsive period of the HPA axis.
This reaction is a specific reaction to pain; in control animals,
an increase in the plasma corticosterone in response to the
procedure of saline injection into the paw was less prolonged
and weaker than the hormonal response to formalin-induced
pain. We have revealed that the characteristic feature of the
dynamics of corticosterone response to inflammatory pain
in infant rats is a gradual increase of hormonal release in
the formalin test, so to the end of the response the level of
corticosterone considerably exceeded its initial level. Most
importantly, the results indicate that 24 hours after the
formalin test, the corticosterone level still exceeds the basal
corticosterone value before the formalin test in males of all
the groups under study. This fact cannot be associated with
an increase in corticosterone basal level in intact 8-day-old
male rats as compared to that in 7-day-olds, as available data
and our own results indicate equal value in the basal level
of plasma corticosterone in 5–8-day-old male rats that were
not exposed to any prenatal impacts [55]. Based on these
results, we conclude that the peripheral link of the HPA axis
responds to inflammatory pain in the formalin test in infant
rats with a prolonged reaction. Experimental data reported
here enhance the idea of relativity of hyporesponsive period
of the HPA axis [20]. Up to now, there has not been any
detailed work done to find a clear explanation for this period
in the development of the HPA axis.
The results obtained provide new important information
that maternal 5-HT1A agonist buspirone prior to stress
during gestation induces in the offspring during the acute
phase in the formalin test the stronger corticosterone increase
as compared to the stress hormonal elevation in animals with
other prenatal treatments. In the following time periods of
formalin-induced pain, the animals with different prenatal
treatments do not show significant differences in stress
corticosterone level. Negative correlation revealed between
the corticosterone concentration and the number of flexes
+ shakes during the first nine minutes after injection of
formalin in buspirone + stress male rats is noteworthy. These
results suggest that activation of the corticosterone release via
5-HT1A receptors may facilitate some adaptive mechanisms
associated with a decrease of inflammatory pain in buspirone
+ stress rats.
There are multiple pathways through which 5-HT and
its agonists may stimulate the HPA axis [56]. It is shown
that formalin activates ascending ways to the HPA [57]. The
chemical stimulus formalin induces appearance of “inflam-
matory soup” from various chemical substances including 5-
HT released from platelets and also activation of neutrophils
and leucocytes that produce proinflammatory cytokines IL-
6 [17]. Cytokines contribute to the increase in ACTH and
corticosterone [17] and to the exacerbation of nociceptive
processing [58]. Interaction between the HPA axis and 5-
HT system would be dependent on concentration of 5-HT
released from platelets during inflammation which reaches
the central nervous sites, but this question is poorly known.
Both systems are highly plastic during maturation [6], and
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prenatal stress impairs interaction between the HPA axis and
5-HT system and alters their functional activity in adults
[2, 35]. The expression of 5-HT1A receptors is found during
the initial stages of prenatal development of the hippocampus
[59] andprenatal stress impairs their development [60].There
is evidence that buspirone penetrates through the placental
and blood brain barriers [61] and is able to exert the protective
effects presumably through its ability to overcome the deficit
of fetal serotonin and to stimulate fetal 5-HT1A receptors
[62]. Further studies are needed to evaluate influences of
maternal buspirone prior to stress during gestation to the
HPA axis response during the inflammatory pain immedi-
ately after finishing the period of responsiveness in the HPA
axis development. Thus, new data indicate an important role
of 5-HT1A receptors in the development of close relationships
between the HPA axis and tonic nociceptive system that
mediate adaptation of organism to extreme conditions.
5. Summary
The formalin-induced pain causes a gradual and prolonged
increase in plasma corticosterone level during the persistent
pain-like behavior in 7-day-oldmale rats. Chronic treatments
of rat dams with buspirone before restraint stress during
gestation normalize in the offspring inflammatory pain
behavior and induce during the acute phase in the formalin
test the stronger corticosterone increase as compared to the
stress hormonal elevation in animals with other prenatal
treatments. Buspirone + stress rats display the negative cor-
relation between plasma corticosterone level and the number
of flexes + shakes. Thus, the new data enhance the idea about
relativity of the HPA axis hyporeactive period and suggest
that maternal buspirone prior to stress during gestation
may enhance an adaptive mechanism of the inflammatory
nociceptive system in the infant male offspring through
activation of the HPA axis peripheral link.
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